Welcome to the European Society for Medical Oncology (ESMO), the leading European professional organization representing medical oncologists. more about ESMO ...
ESMO FAMILY SITES
ESMO NEWS
- 03.09.10 - ESMO E-Learning activities now accredited by ACOE
The Accreditation Council of Oncology in Europe (ACOE) has assessed and recognized the high quality...
- 23.08.10 - Catch up on the latest update on ‘Current concepts in the treatment of colorectal hepatic metastases’ from the ECIO-ESMO joint session.
ESMO Faculty members, Hans-Joachim Schmoll and Alfredo Falcone, were guest speakers at the 2010...
- 10.08.10 - The results of the ESMO Treasurer 2011-2013 election are now in!
We wish to extend our gratitude to the two outstanding candidates: Jean-Yves Blay and Fortunato...
- 05.08.10 - The 6th ESMO E-Learning Module is now available on-line
“The use of biomarkers for treatment decisions in oncology” by Prof. Dr. C. Sessa and Dr. A. Fasolo
- 20.07.10 - José Carreras will perform at the ESMO Foundation Benefit Concert, 10 October 2010, during the 35th ESMO Congress
JOSÉ CARRERAS RETURNS TO LA SCALA
AFTER AN ABSENCE OF 14 YEARS
“CANCER HAS TAUGHT ME TO LISTEN...
[more...]
ONCOLOGY NEWS
- 09.09.10 - A marker of homologous recombination predicts pathological complete response to neoadjuvant anthracycline based chemotherapy in primary breast cancer
Defective homologous recombination is frequent in triple negative breast cancer and identifies...
- 08.09.10 - European Medicines Agency holds first scientific workshop on nanomedicines
Eighteen marketing authorization applications for nanomedicines have been reviewed by the European...
- 07.09.10 - Establishment of a UK-wide network to facilitate the acquisition of quality assured FDG–PET data for clinical trials in lymphoma
Clinical trials network has enabled consistent quality assured PET results obtained from multiple...
- 06.09.10 - Chemotherapy and drug tolerance
A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations
- 03.09.10 - Neoadjuvant chemotherapy or primary surgery in advanced ovarian cancer
Complete resection of all macroscopic disease, whether performed as primary treatment or after...
[more...]
ESMO Practice Tools
myESMO Network
Virtual Meetings
ESMO Fellowships